End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38 CNY | +0.11% | +16.21% | -19.73% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's profit outlook over the next few years is a strong asset.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- With a 2024 P/E ratio at 29.46 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-19.73% | 780M | - | ||
+3.34% | 104B | A- | ||
-7.66% | 62.39B | A- | ||
+72.86% | 48.95B | B | ||
+18.82% | 39.58B | B | ||
+3.62% | 32.08B | A- | ||
+12.35% | 20.22B | B- | ||
+13.00% | 16.86B | C+ | ||
+16.25% | 14.88B | B- | ||
+2.22% | 13.99B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 688378 Stock
- Ratings Jilin OLED Material Tech Co., Ltd.